Aurinia Pharmaceuticals (AUPH) EBITDA (2015 - 2026)
Aurinia Pharmaceuticals posted quarterly EBITDA of $34.1 million for Q1 2026, up 47.09% year-on-year from $23.2 million in Q1 2025, and down 83.85% on a QoQ basis from $210.9 million in Q4 2025.
Aurinia Pharmaceuticals (AUPH) has 12 years of EBITDA data on file, last reported at $34.1 million in Q1 2026.
- For the quarter ending Q1 2026, EBITDA rose 47.09% year-over-year to $34.1 million; the trailing twelve-month figure through Mar 2026 stood at $298.2 million (up 647.75% YoY), and the FY2025 full-year result was $287.2 million, up 4822.88% from the prior year.
- EBITDA for Q1 2026 stood at $34.1 million, down from $210.9 million in the prior quarter.
- Across five years, EBITDA topped out at $210.9 million in Q4 2025 and bottomed at -$38.4 million in Q1 2022.
- The 5-year median for EBITDA is -$8.7 million (2022), against an average of $8.3 million.
- The widest annual swing landed in 2023, when EBITDA slumped 54.38%; it then soared 17975.75% in 2025.
- A 5-year view of EBITDA shows it stood at -$25.6 million in 2022, then retreated by 4.21% to -$26.7 million in 2023, then soared by 104.38% to $1.2 million in 2024, then jumped by 17975.75% to $210.9 million in 2025, then sank by 83.85% to $34.1 million in 2026.
- The last three EBITDA figures came in at $34.1 million (Q1 2026), $210.9 million (Q4 2025), and $31.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -13.63 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -19.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -14.44 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.14 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -3.82 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 661.60 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 201.19 Mn |
| 10 | Aurinia Pharmaceuticals | 2.03 Bn | 1.65 Bn | 71.20 Mn | 34.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.07 Mn |
| Dec 31, 2025 | 210.94 Mn |
| Sep 30, 2025 | 31.71 Mn |
| Jun 30, 2025 | 21.43 Mn |
| Mar 31, 2025 | 23.17 Mn |
| Dec 31, 2024 | 1.17 Mn |
| Sep 30, 2024 | 14.82 Mn |
| Jun 30, 2024 | 717,000.00 |
| Mar 31, 2024 | -10.87 Mn |
| Dec 31, 2023 | -26.66 Mn |
| Sep 30, 2023 | -13.37 Mn |
| Jun 30, 2023 | -11.52 Mn |
| Mar 31, 2023 | -26.13 Mn |
| Dec 31, 2022 | -25.58 Mn |
| Sep 30, 2022 | -8.66 Mn |
| Jun 30, 2022 | -35.75 Mn |
| Mar 31, 2022 | -38.40 Mn |
| Dec 31, 2021 | -33.38 Mn |
| Sep 30, 2021 | -50.26 Mn |
| Jun 30, 2021 | -47.00 Mn |
| Mar 31, 2021 | -50.37 Mn |
| Dec 31, 2020 | -8.07 Mn |
| Sep 30, 2020 | -42.13 Mn |
| Jun 30, 2020 | -26.54 Mn |
| Mar 31, 2020 | -25.93 Mn |
| Dec 31, 2019 | -34.84 Mn |
| Sep 30, 2019 | -24.07 Mn |
| Jun 30, 2019 | -17.14 Mn |
| Mar 31, 2019 | -14.89 Mn |
| Dec 31, 2018 | -14.59 Mn |
| Sep 30, 2018 | -18.34 Mn |
| Jun 30, 2018 | -15.77 Mn |
| Mar 31, 2018 | -15.48 Mn |
| Dec 31, 2017 | -3.32 Mn |
| Sep 30, 2017 | -13.21 Mn |
| Dec 31, 2016 | -8.33 Mn |
| Sep 30, 2016 | -7.42 Mn |
| Sep 30, 2015 | -5.21 Mn |
| Jun 30, 2015 | -733,000.00 |